Home Kinnate Biopharma

Kinnate Biopharma

In operation
IPO
Developer of Novel Kinase Inhibitors

Basic Information

Kinnate Biopharma is a precision oncology company dedicated to developing a range of therapies to treat patients with genomically defined vulnerabilities. Its focus is on the design and development of selective small molecules, with the mission of delivering the right drug to the right patient.
Kinnate Biopharma, Inc.
SanDiego,California,United States of America
less than 15 people
January 01, 2018
--